GERON CORP Restructuring Reserve, Current
GERON CORP (GERN) had Restructuring Reserve, Current of $178.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveCurrent · last filed 2026-08-05
- 2026-06-30: Restructuring Reserve, Current $178.00K.
- 2026-03-31: Restructuring Reserve, Current $3.11M.
- 2025-12-31: Restructuring Reserve, Current $17.03M.
- 2024-12-31: Restructuring Reserve, Current $0.00.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2026-06-30 | $178.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $3.11M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $17.03M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-02 |
| 2016-09-30 | $13.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $19.00K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $35.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $52.00K 10-Q · filed 2016-11-03 |
| 2015-09-30 | $78.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $205.00K 10-Q · filed 2015-08-05 |
| 2015-03-31 | $316.00K 10-Q · filed 2015-05-07 |
| 2014-03-31 | $11.00K 10-Q · filed 2014-05-01 |
| 2013-12-31 | $94.00K 10-K · filed 2015-03-11 |
| 2013-09-30 | $161.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $374.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $843.00K 10-Q · filed 2013-05-03 |
| 2012-12-31 | $1.97M 10-K · filed 2014-03-17 |
| 2012-09-30 | $90.00K 10-Q · filed 2012-11-02 |
| 2012-06-30 | $734.00K 10-Q · filed 2012-08-03 |
| 2012-03-31 | $1.42M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $3.73M 10-K · filed 2013-03-15 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |